ArticlePLoS pathogens2023

Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals.

Jithesh Kottur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.